Delivery Order SPE2DR25D1100-SPE2DR26FDB6H
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,678.08 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with an ultimate completion date of January 13, 2026. This non-set-aside, firm fixed-price delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,144.14 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in a 30-count package, with an ultimate completion date of January 13, 2026. This competitive award, issued on January 12, 2026, utilizes firm fixed-price pricing and does not include a set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,739.72 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This firm fixed-price delivery order was awarded on January 9, 2026, with an ultimate completion date of January 12, 2026, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award is...
- The Defense Logistics Agency (DLA) awarded a $19,458.59 delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Ondansetron ODT 4 mg tablets (30-count packages). The contract represents a firm fixed-price delivery order with an ultimate completion date of January 20, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, a subsidiary...
- The Defense Logistics Agency awarded a delivery order valued at $2,295.50 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order was issued on January 16, 2026, with an ultimate completion date of January 20, 2026. The pharmaceutical product will be performed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under the parent entity...
- The Defense Logistics Agency awarded a $5,011.68 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a completion deadline of December 5, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,734.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 8 mg tablets. The contract has a completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,691.68 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count) on January 13, 2026. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 14, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. The company is a subsidiary of Cencora, Inc.,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,629.35 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with performance to be completed by December 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $11,722.96 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDB6HDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,944.58 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). The contract is a firm fixed-price delivery order with no set-aside designation, reflecting open and competitive procurement. The award was made on January 26, 2026, with an ultimate completion date of January 27, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, with Cencora, Inc. (doing business as AmerisourceBergen) as the parent organization. This delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The Defense Logistics Agency procures these essential pharmaceuticals to support military treatment facilities, veteran healthcare programs, and other federal medical institutions across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 1/25/26 |